
Industry track: Life Sciences Passed
Wednesday February 19, 2025 14:00 - 17:15 Breakout Room 1
Speaker: Emelie Antoni (AstraZeneca)Moderator: Nina Rawal (Trill Impact)
Panelists: Aida Habtezion (Pfizer Inc.), Anders Persson (AstraZeneca), Boubou Hallberg (Sahlgrenska University Hospital), Britta Stenson (Business Sweden), Carl Bennet (Carl Bennet AB ), Christophe Pedroletti (Karolinska University Hospital), Christopher Jon Stokes (Lilly), Diego Ardigò (Chiesi Farmaceutici spa), Gunilla Andrew-Nielsen (Swedish Medical Products Agency), Gunilla Osswald (BioArctic AB), Janet Hoogstraate (NorthX Biologics AB), Jeppe Theisen (Novo Nordisk), Jessica Martinsson (SwedenBIO), Jörg Schulze (Bristol Myers Squibb), Koki Sato (Takeda), Lorenzo Roversi (IonQ), Nasim Bergman Farrokhnia (Microsoft EMEA (Europe, Middle East, and Africa)), Pascal Roché (RAMSAY SANTE), Reagan Jarvis (Anocca ), Richard Rosenquist Brandell (Karolinska Institutet), Roman Stampfli (Amgen), Stefan Hendriks (Novartis), Therese Lindé (Elekta AB), Thomas Allvin (EFPIA), Yoshito Nakanishi (Roche AB)
Industry track host: Acko Ankarberg Johansson (Government Offices of Sweden)
Type: Industry tracks
Setting the scene
- Acko Ankarberg Johansson, Minister for Health Care
AstraZeneca as a cornerstone of Swedish Life Science (Kenote)
- Emelie Antoni, Nordic and Sweden Country President, AstraZeneca
The Swedish infrastructure for Precision Medicine – from molecule to patient benefit (Panel )
Precision medicine is the future of healthcare. Explore how the Swedish innovation- and healthcare system is adapting to future treatments, from diagnosis to treatments.
- Richard Rosenquist Brandell, Professor Karolinska Institute, Genomic Medicine Sweden
- Boubou Hallberg, CEO, Sahlgrenska University Hospital
- Thomas Allvin, Executive Director Strategy and Board Coordination, EFPIA
- Roman Stampfli, Regional General Manager, Amgen
The Swedish springboard for discovery, development and production of advance therapies (Panel)
Sweden is making significant investments to bridge gaps and facilitate the journey from ideas in cell, gene, and tissue therapy to the first clinical batches. Explore how collaborations among organizations, clusters, and industry players are driving the scale-up of advanced therapy medical products (ATMP).
- Janet Hoogstrate, CEO, NorthXBiologics
- Anders Persson, Head of Ecosystem Strategy & Projects, AZ BIO-Venture Hub
- Lorenzo Roversi, Managing Director UK and Nordics, IonQ
Audience discussions and Q&A
Audience is invited to share remarks and insights with regards to the two previous discussions, after a few selected remarks
- Jeppe Theisen, CVP, NovoNordisk
- Diego Ardigo, Executive Vice President Global Research and Development, Chiesi
- Stefan Hendriks, Head Western European Cluster Novartis, Novartis
Clinical Trials and Beyond: Sweden's Commitment to Global Life Sciences Research (Panel)
In the recently updated Life Sciences strategy, Sweden welcomes international collaborations for clinical trials through the launch of a national coordination platform. The Swedish government is announcing substantial investments for research and development in Life Sciences. International partnerships will be significant for enabling these innovation investments to come to life.
- Dr. Aida Habtezion, MD, Chief Medical Officer, Pfizer
- Gunilla Andrew Nielsen, Head of Clinical Trials, Swedish Medical Product Agency
- Dr. Christophe Pedroletti, CEO, Karolinska University Hospital
Digital Healthcare transformation for precision and preventative health (Panel)
Explore how Swedish Healthcare is leading the way, embracing digital technologies to enable patient centric solutions and discuss what the future will bring
- Pascal Roché, Directeur Général, Ramsay Santé
- Nasim Farrokhnia, Industry Director, Healthcare and Life Sciences, Microsoft EMEA
- Therese Lindé, VP Head of Global Policy & Patient Access, Elekta
Seeds of tomorrow: International collaboration for life sciences innovation (Fireside Chat)
Sweden’s Life Science industry plays a crucial role on the global stage. Through international collaborations and partnerships, Swedish companies contribute to global advancements in healthcare. With a high degree of university spin-outs, Sweden enables the commercialization of innovative healthcare solutions, benefiting patients worldwide.
Fireside Chat 1
- Jessica Martinsson, SwedenBIO
- Reagan Jarvis, CEO, Anocca
- Carl Bennet, CEO and Chairman, Carl Bennet AB
Fireside Chat 2
- Thommen Chacko, General Manager Nordics, BMS
- Gunilla Osswald, CEO, BioArctic
Audience discussions and Q&A
Audience is invited to share remarks and insights with regards to the two previous discussions, after a few selected remarks
- Koki Sato, General Manager Nordics, Takeda
- Christopher Stokes, President & GM Northern European Hub, Lilly
- Yoshito Nakanishi, General Manager, Roche
Concluding Remarks
- Acko Ankarberg Johansson, Minister for Health Care
Lecturers
Emelie Antoni Speaker
Nordic and Sweden Country President
AstraZeneca
Nina Rawal Moderator
Partner and Co-Head, Ventures
Trill Impact
Aida Habtezion Panelist
MD, Chief Medical Officer Pfizer
Pfizer Inc.
Anders Persson Panelist
Head of Ecosystem Strategy & Projects
AstraZeneca
Anders is the Head of Ecosystem Strategy and Projects, AstraZeneca in Sweden and is a member of the AstraZeneca Sweden LT. The ecosystem role has a focus on tomorrow's technology and science and to enable a thriving life science scene. Anders has held several project and line management roles in the global AZ R&D organization. After being based in Gaithersburg, Maryland in the USA for a few years, Gothenburg is now his home. In addition to his role within AstraZeneca, Anders is the chairman for the board of SwedenBio (the association for the life science industry in Sweden) and a member of the advisory board for RISE (the Research Institutes of Sweden). Anders has studied biology, chemistry and has a PhD in Biochemistry at Lund University, Sweden.
Boubou Hallberg Panelist
CEO
Sahlgrenska University Hospital
Britta Stenson PanelistPartnerOrganizer
Head of Life Science
Business Sweden
Carl Bennet Panelist
CEO & Chairman
Carl Bennet AB
Christophe Pedroletti Panelist
CEO
Karolinska University Hospital
Christopher Jon Stokes Panelist
President & GM Northern European Hub
Lilly
Diego Ardigò Panelist
Executive Vice President Global Research and Development
Chiesi Farmaceutici spa
Gunilla Andrew-Nielsen PanelistPartner
Head of Clinical Trials
Swedish Medical Products Agency
Gunilla Osswald Panelist
CEO
BioArctic AB
Janet Hoogstraate Panelist
CEO
NorthX Biologics AB
Janet has her academic background from Leiden University in the Netherlands (PhD in Biopharmaceutical Sciences), has done research at Univ. of Utah and Univ. of Iowa and has an EMBA from Hult International School in London. Her research has focused on transport mechanisms and drug properties from drug delivery and absorption to distribution to the brain. Janet has worked in R&D in AstraZeneca in Neuroscience and Pain.
Janet har started Biovation Park in Södertälje, and proceeded her career at Valneva Sweden in vaccine manufacturing, including establishing a large scale vaccine product manufacturing facility during the pandemic.
Currently as CEO of NorthX Biologics, a CDMO and infrastructure in manufacturing of advanced biologics, she strives to bring innovative therapies to patients.
Janet is a member of the Board of Mireca Medicines GmbH, Alzecure Pharma AB and APL AB, and is the industry chair of the working group of process development and manufacturing in SwedenBio.
Jeppe Theisen Panelist
CVP
Novo Nordisk
Jessica Martinsson Panelist
CEO
SwedenBIO
Jörg Schulze Panelist
General Manager Nordics
Bristol Myers Squibb
Koki Sato Panelist
General Manager Nordics
Takeda
Lorenzo Roversi Panelist
Managing Director UK and Nordics
IonQ
Lorenzo Roversi is responsible for building the Quantum Economy in the UK and Nordics. Working with governments, research and enterprise to develop and deploy Quantum Computing, Networking and Quantum Applications across industries including Life Sciences, Automotive, Telecommunications, Aerospace and Financial Services
Prior to joining IonQ Lorenzo spent 15 years with IBM where he held leadership positions in Sweden, India and Switzerland. Lorenzo is an engaged board member with several European and North American Medtech and AI companies.
Nasim Bergman Farrokhnia Panelist
Industry Director, Healthcare and Life Sciences
Microsoft EMEA (Europe, Middle East, and Africa)
I’m Medical doctor and affiliated researcher at Karolinska Institute in Sthlm. I serve as the Industry Director, healthcare and life sciences, Microsoft EMEA (Europe, Middle East, and Africa). I am also the chair of eHealth Doctors within the Swedish Medical Association, and the co-founder of www.digitalcareresearch.com
Pascal Roché Panelist
Directeur Général
RAMSAY SANTE
Reagan Jarvis Panelist
CEO
Anocca
Richard Rosenquist Brandell Panelist
Professor
Karolinska Institutet
Roman Stampfli Panelist
Regional General Manager
Amgen
Stefan Hendriks Panelist
Head Western European Cluster Novartis
Novartis
Therese Lindé Panelist
VP Head of Global Policy & Patient Access
Elekta AB
Thomas Allvin Panelist
Executive Director Strategy and Board Coordination
EFPIA
Yoshito Nakanishi Panelist
General Manager
Roche AB
Acko Ankarberg Johansson Industry track hostPartner
Minister for Health Care
Government Offices of Sweden